Introduction Cardiovascular nuclear medicine imaging techniques are part of the ever-growing clinical noninvasive imaging armamentarium for the evaluation of suspected or known coronary artery disease (CAD). These techniques provide valuable…
Introduction Myocardial infarction (MI) is caused by atherothrombosis (see Chapter 3 ), with platelets playing a pivotal role in the initial onset of MI and its recurrence. Antiplatelet therapy targets…
Introduction Improvement in the acute treatment of myocardial infarction (MI) has made it possible for many patients to survive an initial MI and subsequently be exposed to the risk of…
Introduction Despite significant advances in the diagnosis and treatment of malignant cardiac arrhythmias, sudden cardiac death (SCD) occurs in 180,000 to 250,000 people annually, mostly in patients with coronary artery…
Introduction Evidence-based treatments for patients with myocardial infarction (MI) have improved outcomes, with substantive reductions in mortality rates ( Chapter 2 ). Nevertheless, patients who survive an acute MI remain…
Introduction Mortality for patients with myocardial infarction (MI) remains unacceptably high despite improvements in medical therapy and revascularization. Death, when it occurs, is often caused by cardiac dysfunction, which leads…
Introduction Myocardial infarction (MI) is defined by myocyte necrosis. If large in its territory or critical in its location, this injury can lead to loss of contractile function or other…
Introduction Noninvasive testing after presentation with acute myocardial infarction (MI) plays an essential role in patient management. Noninvasive testing complements clinical assessment of risk stratification and can be used to…
Introduction There has been a major decline in the incidence of myocardial infarction (MI) in the developed world, with the proportion of ST-elevation MI (STEMI) decreasing and the proportion of…
Introduction The combination of aspirin with P2Y 12 inhibitors, which is also known as dual antiplatelet therapy, is the standard of care for oral antiplatelet treatment in patients presenting with…
